| Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Journal Article
- Language: English
- [Odontology] 2023 Oct; Vol. 111 (4), pp. 891-903. <i>Date of Electronic Publication: </i>2023 Mar 15.
- MeSH Terms: Tooth Socket* / pathology ; Tooth Socket* / surgery ; Wound Healing* / physiology ; Male ; Mice ; Animals ; Tooth Extraction ; Acetates / pharmacology
- References: Spector AA, Kim HY. Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism. Biochim Biophys Acta. 2015;1851:356–65. (PMID: 2509361310.1016/j.bbalip.2014.07.020) ; Bennett M, Gilroy DW. Lipid mediators in inflammation. Microbiol Spectr. 2016. https://doi.org/10.1128/microbiolspec.MCHD-0035-2016 . (PMID: 10.1128/microbiolspec.MCHD-0035-201627837747) ; Feuerstein G, Hallenbeck JM. Leukotrienes in health and disease. FASEB J. 1987;1:186–92. (PMID: 304050510.1096/fasebj.1.3.3040505) ; Grosser T, Fries S, FitzGerald GA. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest. 2006;116:4–15. (PMID: 16395396132326910.1172/JCI27291) ; Smyth EM, Grosser T, Wang M, Yu Y, FitzGerald GA. Prostanoids in health and disease. J Lipid Res. 2009;50(Suppl):S423–8. (PMID: 19095631267474510.1194/jlr.R800094-JLR200) ; Lisowska B, Kosson D, Domaracka K. Lights and shadows of NSAIDs in bone healing: the role of prostaglandins in bone metabolism. Drug Des Devel Ther. 2018;12:1753–8. (PMID: 29950809601439210.2147/DDDT.S164562) ; Saul D, Ninkovic M, Komrakova M, Wolff L, Simka P, Gasimov T, Menger B, Hoffmann DB, Rohde V, Sehmisch S. Effect of zileuton on osteoporotic bone and its healing, expression of bone, and brain genes in rats. J Appl Physiol. 2018;124:118–30. (PMID: 2886017710.1152/japplphysiol.01126.2016) ; White AE, Henry JK, Dziadosz D. The Effect of Nonsteroidal Anti-inflammatory Drugs and Selective COX-2 Inhibitors on Bone Healing. HSS J. 2021;17:231–4. (PMID: 34421436836159010.1177/1556331621998634) ; Kam PC, See AU. Cyclo-oxygenase isoenzymes: physiological and pharmacological role. Anaesthesia. 2000;55:442–9. (PMID: 1079213510.1046/j.1365-2044.2000.01271.x) ; Zhang X, Schwarz EM, Young DA, Puzas JE, Rosier RN, O’Keefe RJ. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest. 2002;109:1405–15. (PMID: 1204525415100110.1172/JCI0215681) ; Simon AM, O’Connor JP. Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing. J Bone Joint Surg Am. 2007;89:500–11. (PMID: 1733209810.2106/00004623-200703000-00006) ; Brock TG. Regulating leukotriene synthesis: the role of nuclear 5-lipoxygenase. J Cell Biochem. 2005;96:1203–11. (PMID: 1621598210.1002/jcb.20662) ; Peters-Golden M, Henderson WR Jr. Leukotrienes. N Engl J Med. 2007;357:1841–54. (PMID: 1797829310.1056/NEJMra071371) ; Peters-Golden M. Cell biology of the 5-lipoxygenase pathway. Am J Respir Crit Care Med. 1998;157:S227–31. (PMID: 964760410.1164/ajrccm.157.6.mar4) ; Lee JM, Park H, Noh AL, Kang JH, Chen L, Zheng T, Lee J, Ji SY, Jang CY, Shin CS, Ha H, Lee ZH, Park HY, Lee DS, Yim M. 5-Lipoxygenase mediates RANKL-induced osteoclast formation via the cysteinyl leukotriene receptor 1. J Immunol. 2012;189:5284–92. (PMID: 2310972710.4049/jimmunol.1003738) ; Offenbacher S, Odle BM, Van Dike TE. Endotoxin mediated leukotriene release from bone culture. J Den Res. 1986;65:351. ; Gallwitz WE, Mundy GR, Lee CH, Qiao M, Roodman GD, Raftery M, Gaskell SJ, Bonewald LF. 5-Lipoxygenase metabolites of arachidonic acid stimulate isolated osteoclasts to resorb calcified matrices. J Biol Chem. 1993;268:10087–94. (PMID: 848667710.1016/S0021-9258(18)82175-5) ; Garcia C, Boyce BF, Gilles J, Dallas M, Qiao M, Mundy GR, Bonewald LF. Leukotriene B4 stimulates osteoclastic bone resorption both in vitro and in vivo. J Bone Miner Res. 1996;11:1619–27. (PMID: 891576910.1002/jbmr.5650111105) ; Bonewald LF, Flynn M, Qiao M, Dallas MR, Mundy GR, Boyce BF. Mice lacking 5-lipoxygenase have increased cortical bone thickness. Adv Exp Med Biol. 1997;433:299–302. (PMID: 956115610.1007/978-1-4899-1810-9_63) ; Manigrasso MB, O’Connor JP. Accelerated fracture healing in mice lacking the 5-lipoxygenase gene. Acta Orthop. 2010;81:748–55. (PMID: 21067431321608810.3109/17453674.2010.533931) ; Biguetti CC, Couto MCR, Silva ACR, Shindo JVTC, Rosa VM, Shinohara AL, Andreo JC, Duarte MAH, Wang Z, Brotto M, Matsumoto MA. New surgical model for bone-muscle injury reveals age and gender-related healing patterns in the 5 lipoxygenase (5LO) knockout mouse. Front Endocrinol. 2020;11:484. (PMID: 10.3389/fendo.2020.00484) ; Wixted JJ, Fanning PJ, Gaur T, O’Connell SL, Silva J, Mason-Savas A, Ayers DC, Stein GS, Lian JB. Enhanced fracture repair by leukotriene antagonism is characterized by increased chondrocyte proliferation and early bone formation: a novel role of the cysteinyl LT-1 receptor. J Cell Physiol. 2009;221:31–9. (PMID: 19544365361756010.1002/jcp.21809) ; Cottrell JA, Keshav V, Mitchell A, O’Connor JP. Local inhibition of 5-lipoxygenase enhances bone formation in a rat model. Bone Joint Res. 2013;2:41–50. (PMID: 23610701362621510.1302/2046-3758.22.2000066) ; Simionato GB, da Silva ACR, Oliva AH, de Abreu Furquim EM, Couto MCR, Shinohara AL, Biguetti CC, Matsumoto MA. Lack of 5-lipoxygenase in intramembranous and endochondral 129Sv mice skeleton and intramembranous healing. Arch Oral Biol. 2021;131: 105266. (PMID: 3457139410.1016/j.archoralbio.2021.105266) ; Mahmoud RH, Biguetti CC, Simionato GB, Custódio IC, Silva RBP, Duarte MAH, Faverani LP, Ervolino E, Fakhouri WD, Matsumoto MA. Alveolar socket healing in 5-lipoxygenase knockout aged female mice treated or not with high dose of zoledronic acid. Sci Rep. 2021;11:19535. (PMID: 34599216848674910.1038/s41598-021-98713-2) ; Bousquet J, Demoly P, Humbert M. Montelukast in guidelines and beyond. Adv Ther. 2009;26:575–87. (PMID: 1956227510.1007/s12325-009-0038-1) ; Krishnamoorthy M, Mohd Noor N, Mat Lazim N, Abdullah B. Efficacy of Montelukast in Allergic Rhinitis Treatment: A systematic review and meta-analysis. Drugs. 2020;80:1831–51. (PMID: 3291544110.1007/s40265-020-01406-9) ; Zheng C, Shi X. Cysteinyl leukotriene receptor 1 (cysLT1R) regulates osteoclast differentiation and bone resorption. Artif Cells Nanomed Biotechnol. 2018;46(sup3):S64–70. (PMID: 3018337810.1080/21691401.2018.1489264) ; Wei J, Chen S, Huang C, Guo W, Yang S, Feng B, Chu J. Antagonism of cysteinyl leukot-riene receptor 1 (cysLT1R) by montelukast regulates differentiation of MC3T3-E1 cells under overloaded mechanical environment. Biochem Biophys Res Commun. 2018;495:995–1001. (PMID: 2903219810.1016/j.bbrc.2017.10.051) ; Sabbah W, Slade GD, Sanders AE, Bernabé E. Denture wearing and mortality risk in edentulous American adults: A propensity score analysis. J Dent. 2020;100: 103360. (PMID: 3240425610.1016/j.jdent.2020.103360) ; Bhattacharyya S, Choudhury S, Datta P, Pal AK, Roy S, Chatterjee R, De R, Chakraborty A, Saha S, Chowdhury AR. Assessment of jaw bone quality for designing patient-specific dental implant using computed tomography data. J Long Term Eff Med Implants. 2021;31:49–58. (PMID: 3382253410.1615/JLongTermEffMedImplants.2021036995) ; Scarano A, Bernardi S, Rastelli C, Mortellaro C, Vittorini P, Falisi G. Soft tissue augmentation by means of silicon expanders prior to bone volume increase: a case series. J Biol Regul Homeost Agents. 2019;33(6 Suppl. 2):77–84. (PMID: 32425027) ; Bernardi S, Macchiarelli G, Bianchi S. Autologous materials in regenerative dentistry: harvested bone, platelet concentrates and dentin derivates. Molecules. 2020;25:5330. (PMID: 33203172769651010.3390/molecules25225330) ; Bianchi S, Mancini L, Torge D, Cristiano L, Mattei A, Varvara G, Macchiarelli G, Marchetti E, Bernardi S. Bio-morphological reaction of human periodontal ligament fibroblasts to different types of dentinal derivates in vitro study. Int J Mol Sci. 2021;22:8681. (PMID: 34445386839540710.3390/ijms22168681) ; Bianchi S, Bernardi S, Mattei A, Cristiano L, Mancini L, Torge D, Varvara G, Macchiarelli G, Marchetti E. Morphological and biological evaluations of human periodontal ligament fibroblasts in contact with different bovine bone grafts treated with low-temperature deproteinisation protocol. Int J Mol Sci. 2022;23:5273. (PMID: 35563664910106210.3390/ijms23095273) ; Bianchi S, Torge D, Rinaldi F, Piattelli M, Bernardi S, Varvara G. Platelets’ role in dentistry: from oral pathology to regenerative potential. Biomedicines. 2022;10:218. (PMID: 35203428886941010.3390/biomedicines10020218) ; Percie du Sert N, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, Emerson M, Garner P, Holgate ST, Howells DW, Hurst V, Karp NA, Lazic SE, Lidster K, MacCallum CJ, Macleod M, Pearl EJ, Petersen OH, Rawle F, Reynolds P, Rooney K, Sena ES, Silberberg SD, Steckler T, Würbel H. Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 20. PLoS Biol. 2020;18:e3000411. (PMID: 32663221736002510.1371/journal.pbio.3000411) ; Biguetti CC, Vieira AE, Cavalla F, Fonseca AC, Colavite PM, Silva RM, Trombone APF, Garlet GP. CCR2 contributes to F4/80+ cells migration along intramembranous bone healing in maxilla, but its deficiency does not critically affect the healing outcome. Front Immunol. 2018;9:1804. (PMID: 30147688609599710.3389/fimmu.2018.01804) ; Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Müller R. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 2010;25:1468–86. (PMID: 2053330910.1002/jbmr.141) ; Laidler PM, Taga EM, Van Etten RL. Human liver acid phosphatases: cysteine residues of the low-molecular-weight enzyme. Arch Biochem Biophys. 1982;216:512–21. (PMID: 711484910.1016/0003-9861(82)90240-5) ; Chaves Neto AH, Machado D, Yano CL, Ferreira CV. Antioxidant defense and apoptotic effectors in ascorbic acid and β-glycerophosphate-induced osteoblastic differentiation. Dev Growth Differ. 2011;53:88–96. (PMID: 2126161410.1111/j.1440-169X.2010.01232.x) ; Granjeiro JM, Taga EM, Aoyama H. Purification and characterization of a low-molecular-weight bovine kidney acid phosphatase. An Acad Bras Cienc. 1997;69(4):451–60. (PMID: 9629311) ; Janckila AJ, Parthasarathy RN, Parthasarathy LK, Seelan RS, Hsueh YC, Rissanen J, Alatalo SL, Halleen JM, Yam LT. Properties and expression of human tartrate-resistant acid phosphatase isoform 5a by monocyte-derived cells. J Leukoc Biol. 2005;77:209–18. (PMID: 1554254310.1189/jlb.0504287) ; Karmen A. A note on the spectrometric assay of glutamic-oxalacetic transaminase in human blood serum. J Clin Invest. 1955;34:131–3. (PMID: 13221664) ; Henry RJ, Chiamorin N, Bolub OJ, Berkman S. Revised spectrophotometric methods for the determination of glutamic-oxalacetic transaminase, glutamic-pyruvic transaminase, and lactic acid dehydrogenase. Am J Clin Pathol. 1960;34:381–98. (PMID: 1371343810.1093/ajcp/34.4_ts.381) ; Garcia C, Qiao M, Chen D, Kirchen M, Gallwitz W, Mundy GR, Bonewald LF. Effects of synthetic peptido-leukotrienes on bone resorption in vitro. J Bone Miner Res. 1996;11:521–9. (PMID: 899288310.1002/jbmr.5650110413) ; Traianedes K, Dallas MR, Garrett IR, Mundy GR, Bonewald LF. 5-Lipoxygenase metabolites inhibit bone formation in vitro. Endocrinology. 1998;139:3178–84. (PMID: 964569110.1210/endo.139.7.6115) ; Silva RCS, Agrelli A, Andrade AN, Mendes-Marques CL, Arruda IRS, Santos LRL, Vasconcelos NF, Machado G. Titanium dental implants: an overview of applied nanobiotechnology to improve biocompatibility and prevent infections. Materials. 2022;15:3150. (PMID: 35591484910468810.3390/ma15093150) ; Barone A, Ricci M, Tonelli P, Santini S, Covani U. Tissue changes of extraction sockets in humans: a comparison of spontaneous healing vs. ridge preservation with secondary soft tissue healing. Clin Oral Implants Res. 2013;24:1231–7. (PMID: 22784417) ; Shuto T, Sarkar G, Bronk JT, Matsui N, Bolander ME. Osteoblasts express types I and II activin receptors during early intramembranous and endochondral bone formation. J Bone Miner Res. 1997;12:403–11. (PMID: 907658310.1359/jbmr.1997.12.3.403) ; Denzlinger C, Rapp S, Hagmann W, Keppler D. Leukotrienes as mediators in tissue trauma. Science. 1985;230:330–2. (PMID: 404893710.1126/science.4048937) ; Akino K, Mineda T, Mori N, Hirano A, Imaizumi T, Akita S. Attenuation of cysteinyl leukotrienes induces human mesenchymal stem cell differentiation. Wound Repair Regen. 2006;14:343–9. (PMID: 1680881410.1111/j.1743-6109.2006.00130.x) ; Kang JH, Lim H, Lee DS, Yim M. Montelukast inhibits RANKL-induced osteoclast formation and bone loss via CysLTR1 and P2Y12. Mol Med Rep. 2018;18:2387–98. (PMID: 29916540) ; Tintinger GR, Feldman C, Theron AJ, Anderson R. Montelukast: more than a cysteinyl leukotriene receptor antagonist? Sci World J. 2010;10:2403–13. (PMID: 10.1100/tsw.2010.229) ; Perwad F, Azam N, Zhang MY, Yamashita T, Tenenhouse HS, Portale AA. Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice. Endocrinology. 2005;146:5358–64. (PMID: 1612315410.1210/en.2005-0777) ; Lieben L, Masuyama R, Torrekens S, Van Looveren R, Schrooten J, Baatsen P, Lafage-Proust MH, Dresselaers T, Feng JQ, Bonewald LF, Meyer MB, Pike JW, Bouillon R, Carmeliet G. Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization. J Clin Invest. 2012;122:1803–15. (PMID: 22523068333697010.1172/JCI45890) ; Härle D, Rådmark O, Samuelsson B, Steinhilber D. Calcitriol and transforming growth factor-beta upregulate 5-lipoxygenase mRNA expression by increasing gene transcription and mRNA maturation. Eur J Biochem. 1998;254:275–81. (PMID: 966018010.1046/j.1432-1327.1998.2540275.x) ; Seuter S, Väisänen S, Rådmark O, Carlberg C, Steinhilber D. Functional characterization of vitamin D responding regions in the human 5-Lipoxygenase gene. Biochim Biophys Acta. 2007;1771:864–72. (PMID: 1750003210.1016/j.bbalip.2007.04.007) ; Stelmach I, Olszowiec-Chlebna M, Jerzynska J, Grzelewski T, Stelmach W, Majak P. Inhaled corticosteroids may have a beneficial effect on bone metabolism in newly diagnosed asthmatic children. Pulm Pharmacol Ther. 2011;24:414–20. (PMID: 2125199310.1016/j.pupt.2011.01.004) ; Everts V, de Vries TJ, Helfrich MH. Osteoclast heterogeneity: lessons from osteopetrosis and inflammatory conditions. Biochim Biophys Acta. 2009;1792:757–65. (PMID: 1946511810.1016/j.bbadis.2009.05.004) ; Currie GP, Srivastava P, Dempsey OJ, Lee DK. Therapeutic modulation of allergic airways disease with leukotriene receptor antagonists. QJM. 2005;98:171–82. (PMID: 1572839810.1093/qjmed/hci024) ; Clarridge K, Chin S, Eworuke E, Seymour S. A Boxed Warning for Montelukast: The FDA Perspective. J Allergy Clin Immunol Pract. 2021;9:2638–41. (PMID: 3374447110.1016/j.jaip.2021.02.057) ; Incecik F, Onlen Y, Sangun O, Akoglu S. Probable montelukast-induced hepatotoxicity in a pediatric patient: case report. Ann Saudi Med. 2007;27:462–3. (PMID: 180591266074176) ; Calapai G, Casciaro M, Miroddi M, Calapai F, Navarra M, Gangemi S. Montelukast-induced adverse drug reactions: a review of case reports in the literature. Pharmacology. 2014;94:60–70. (PMID: 2519609910.1159/000366164) ; Lebensztejn DM, Bobrus-Chociej A, Kłusek M, Uscinowicz M, Lotowska J, Sobaniec-Lotowska M, Kaczmarski M. Hepatotoxicity caused by montelukast in a paediatric patient. Prz Gastroenterol. 2014;9:121–3. (PMID: 250614944108756) ; El-Boghdady NA, Abdeltawab NF, Nooh MM. Resveratrol and Montelukast alleviate paraquat-induced hepatic injury in mice: modulation of oxidative stress, inflammation, and apoptosis. Oxid Med Cell Longev. 2017;2017:9396425. (PMID: 29201275567174910.1155/2017/9396425) ; Pu S, Liu Q, Li Y, Li R, Wu T, Zhang Z, Huang C, Yang X, He J. Montelukast prevents mice against acetaminophen-induced liver injury. Front Pharmacol. 2019;10:1070. (PMID: 31620001675981710.3389/fphar.2019.01070) ; El-Kashef DH, Zaghloul RA. Ameliorative effect of montelukast against carbon tetrachloride-induced hepatotoxicity: Targeting NLRP3 inflammasome pathway. Life Sci. 2022;304: 120707. (PMID: 3569010610.1016/j.lfs.2022.120707)
- Grant Information: 2019/16067-3 Fundação de Amparo à Pesquisa do Estado de São Paulo; 42338.63998.1205.2019 Fundação de Amparo à Pesquisa do Estado do Amazonas
- Contributed Indexing: Keywords: 5-Leukotriene; Bone tissue; Cysteinyl leukotrienes; Dental socket; Mice
- Substance Nomenclature: MHM278SD3E (montelukast) ; 0 (Acetates)
- Entry Date(s): Date Created: 20230315 Date Completed: 20230911 Latest Revision: 20230922
- Update Code: 20240513
|
